TBPH Competitors & Alternatives
Compare Theravance Biopharma Inc with similar stocks in the same industry
Biotechnology
TBPH
Main Stock$16.93
Tradestie Score
59
Market Cap
$726.21M
P/E Ratio
7.6
Revenue Growth
0.2%
Analyst Upside
-2.5%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GERN
Geron Corp
|
$1.36
|
$899.60M | - | 53 | Compare |
|
ANAB
AnaptysBio, Inc. Common Stock
|
$63.42
|
$894.30M | - | 57 | Compare |
|
EYPT
EyePoint Pharmaceuticals, Inc. Common Stock
|
$13.98
|
$890.20M | - | 56 | Compare |
|
TNGX
Tango Therapeutics, Inc.
|
$29.46
|
$887.30M | - | 60 | Compare |
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$4.87
|
$879.90M | 5.7 | 56 | Compare |
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$11.20
|
$871.90M | - | 57 | Compare |
|
DNA
Ginkgo Bioworks Holdings, Inc.
|
$10.40
|
$868.46M | - | 60 | Compare |
|
TSHA
Taysha Gene Therapies, Inc. Common Stock
|
$6.53
|
$867.49M | - | 58 | Compare |
|
FTRE
Fortrea Holdings Inc. Common Stock
|
$17.28
|
$864.42M | - | 58 | Compare |
|
CRMD
CorMedix Inc.
|
$8.75
|
$862.55M | 3.9 | 57 | Compare |
More TBPH Analysis
Data updated: Jul 05, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry